Live Attenuated Vaccines Market Report

Global and Region Live Attenuated Vaccines Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：170
  • REPORT CODE：GMM902247
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated vaccine).

    Examples of live attenuated) vaccines include: Viral: measles vaccine, mumps vaccine, rubella vaccine and live attenuated influenza vaccine (the seasonal flu nasal spray and the 2009 H1N1 flu nasal spray), etc; Bacterial: BCG vaccine, oral typhoid vaccine and epidemic typhus vaccine.

    The report details the trend, potential and market size of Live Attenuated Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Live Attenuated Vaccinesmarket, defines the market attractiveness level of Live Attenuated Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Live Attenuated Vaccines industry, describes the types of Live Attenuated Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Live Attenuated Vaccines market and the development prospects and opportunities of Live Attenuated Vaccines industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Live Attenuated Vaccines market in Chapter 13.

    By Player:

    • Sanofi

    • Serum Institute Of India

    • Pfizer

    • Merck

    • CSL

    • Astellas Pharma

    • Johnson & Johnson

    • GlaxoSmithKline

    By Type:

    • Bacterial

    • Viral

    By End-User:

    • Hospitals

    • Clinics

    • Research Institutes

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Live Attenuated Vaccines Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Live Attenuated Vaccines Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Live Attenuated Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Live Attenuated Vaccines Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Live Attenuated Vaccines Market Analysis and Outlook to 2022

    • 7.1 Global Live Attenuated Vaccines Consumption (2017-2022)

    • 7.2 United States Live Attenuated Vaccines Consumption (2017-2022)

    • 7.3 Europe Live Attenuated Vaccines Consumption (2017-2022)

    • 7.4 China Live Attenuated Vaccines Consumption (2017-2022)

    • 7.5 Japan Live Attenuated Vaccines Consumption (2017-2022)

    • 7.6 India Live Attenuated Vaccines Consumption (2017-2022)

    • 7.7 South Korea Live Attenuated Vaccines Consumption (2017-2022)

    8 Region and Country-wise Live Attenuated Vaccines Market Analysis and Outlook to 2028

    • 8.1 Global Live Attenuated Vaccines Consumption Forecast (2022-2028)

    • 8.2 United States Live Attenuated Vaccines Consumption Forecast (2022-2028)

    • 8.3 Europe Live Attenuated Vaccines Consumption Forecast (2022-2028)

    • 8.4 China Live Attenuated Vaccines Consumption Forecast (2022-2028)

    • 8.5 Japan Live Attenuated Vaccines Consumption Forecast (2022-2028)

    • 8.6 India Live Attenuated Vaccines Consumption Forecast (2022-2028)

    • 8.7 South Korea Live Attenuated Vaccines Consumption Forecast (2022-2028)

    9 Global Live Attenuated Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Live Attenuated Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Bacterial Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Viral Consumption and Growth Rate (2017-2022)

    • 9.2 Global Live Attenuated Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Research Institutes Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Live Attenuated Vaccines Market Outlook by Types and Applications to 2028

    • 10.1 Global Live Attenuated Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Bacterial Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Viral Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Live Attenuated Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Live Attenuated Vaccines Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Live Attenuated Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Live Attenuated Vaccines Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Live Attenuated Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Live Attenuated Vaccines Market Competitive Analysis

    • 14.1 Sanofi

      • 14.1.1 Sanofi Company Details

      • 14.1.2 Sanofi Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Sanofi Live Attenuated Vaccines Product and Service

    • 14.2 Serum Institute Of India

      • 14.2.1 Serum Institute Of India Company Details

      • 14.2.2 Serum Institute Of India Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Serum Institute Of India Live Attenuated Vaccines Product and Service

    • 14.3 Pfizer

      • 14.3.1 Pfizer Company Details

      • 14.3.2 Pfizer Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Pfizer Live Attenuated Vaccines Product and Service

    • 14.4 Merck

      • 14.4.1 Merck Company Details

      • 14.4.2 Merck Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Merck Live Attenuated Vaccines Product and Service

    • 14.5 CSL

      • 14.5.1 CSL Company Details

      • 14.5.2 CSL Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 CSL Live Attenuated Vaccines Product and Service

    • 14.6 Astellas Pharma

      • 14.6.1 Astellas Pharma Company Details

      • 14.6.2 Astellas Pharma Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Astellas Pharma Live Attenuated Vaccines Product and Service

    • 14.7 Johnson & Johnson

      • 14.7.1 Johnson & Johnson Company Details

      • 14.7.2 Johnson & Johnson Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Johnson & Johnson Live Attenuated Vaccines Product and Service

    • 14.8 GlaxoSmithKline

      • 14.8.1 GlaxoSmithKline Company Details

      • 14.8.2 GlaxoSmithKline Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 GlaxoSmithKline Live Attenuated Vaccines Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Live Attenuated Vaccines

    • Figure Live Attenuated Vaccines Picture

    • Table Global Live Attenuated Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Live Attenuated Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Live Attenuated Vaccines Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Live Attenuated Vaccines Consumption by Country (2017-2022)

    • Figure United States Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)

    • Figure China Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Live Attenuated Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Live Attenuated Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Live Attenuated Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bacterial Consumption and Growth Rate (2017-2022)

    • Figure Global Viral Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Research Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Bacterial Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Viral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Live Attenuated Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Live Attenuated Vaccines Export by Region (Top 5 Countries) (2017-2028)

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Live Attenuated Vaccines Product and Service

    • Table Serum Institute Of India (Foundation Year, Company Profile and etc.)

    • Table Serum Institute Of India Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute Of India Live Attenuated Vaccines Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Live Attenuated Vaccines Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Live Attenuated Vaccines Product and Service

    • Table CSL (Foundation Year, Company Profile and etc.)

    • Table CSL Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Live Attenuated Vaccines Product and Service

    • Table Astellas Pharma (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Live Attenuated Vaccines Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Live Attenuated Vaccines Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Live Attenuated Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Live Attenuated Vaccines Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US